CHEMFAB ALKALIS has announced its results for the year ended March 2022. Let us have a look at the detailed performance review of the company during FY21-22.
No. of Mths Year Ending | 12 Mar-21* | 12 Mar-22* | % Change | |
---|---|---|---|---|
Net Sales | Rs m | 1,808 | 2,716 | 50.2% |
Other income | Rs m | 14 | 57 | 306.0% |
Total Revenues | Rs m | 1,822 | 2,773 | 52.2% |
Gross profit | Rs m | 236 | 567 | 140.3% |
Depreciation | Rs m | 202 | 222 | 9.9% |
Interest | Rs m | 28 | 11 | -59.5% |
Profit before tax | Rs m | 20 | 391 | 1,830.0% |
Tax | Rs m | 102 | 104 | 1.9% |
Profit after tax | Rs m | -81 | 287 | NA |
Gross profit margin | % | 13.1 | 20.9 | |
Effective tax rate | % | 501.3 | 26.5 | |
Net profit margin | % | -4.5 | 10.6 |
5 PM TODAY: Golden Buying Window to Ride India's Potentially Decade-Long $10 Trillion Bull Run...
No. of Mths Year Ending | 12 Mar-21* | 12 Mar-22* | % Change | |
---|---|---|---|---|
Networth | Rs m | 2,668 | 2,971 | 11.4 |
Current Liabilities | Rs m | 416 | 578 | 39.1 |
Long-term Debt | Rs m | 234 | 0 | -100.0 |
Total Liabilities | Rs m | 3,221 | 3,494 | 8.5 |
Current assets | Rs m | 758 | 994 | 31.1 |
Fixed Assets | Rs m | 2,463 | 2,500 | 1.5 |
Total Assets | Rs m | 3,221 | 3,494 | 8.5 |
Particulars | No. of months | 12 | 12 | % Change |
---|---|---|---|---|
Year Ending | Mar-21 | Mar-22 | ||
Cash Flow from Operating Activities | Rs m | 454 | 549 | 20.9% |
Cash Flow from Investing Activities | Rs m | -64 | -210 | - |
Cash Flow from Financing Activities | Rs m | -156 | -246 | - |
Net Cash Flow | Rs m | 234 | 93 | -60.2% |
No. of Mths Year Ending | 12 Mar-21* | 12 Mar-22* | |
---|---|---|---|
Sales per share (Unadj.) | Rs | 128.6 | 192.2 |
TTM Earnings per share | Rs | -5.8 | 20.3 |
Diluted earnings per share | Rs | -5.8 | 20.3 |
Price to Cash Flow | x | 14.7 | 5.4 |
TTM P/E ratio | x | -21.8 | 13.4 |
Price / Book Value ratio | x | 0.7 | 0.9 |
Market Cap | Rs m | 1,854 | 2,733 |
Dividends per share (Unadj.) | Rs | 0.0 | 1.3 |
Current Ratio: The company's current ratio deteriorated and stood at 1.7x during FY22, from 1.8x during FY21. The current ratio measures the company's ability to pay short-term and long-term obligations.
Interest Coverage Ratio: The company's interest coverage ratio improved and stood at 35.9x during FY22, from 1.7x during FY21. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.
Return on Equity (ROE): The ROE for the company improved and stood at 9.7% during FY22, from -3.0% during FY22. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.
Return on Capital Employed (ROCE): The ROCE for the company improved and stood at 13.5% during FY22, from 1.7% during FY21. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.
Return on Assets (ROA): The ROA of the company improved and stood at 8.5% during FY22, from -1.7% during FY21. The ROA measures how efficiently the company uses its assets to generate earnings.
No. of Mths Year Ending | 12 Mar-21* | 12 Mar-22* | |
---|---|---|---|
Current ratio | x | 1.8 | 1.7 |
Debtors’ Days | Days | 306 | 288 |
Interest coverage | x | 1.7 | 35.9 |
Debt to equity ratio | x | 0.1 | 0.0 |
Return on assets | % | -1.7 | 8.5 |
Return on equity | % | -3.0 | 9.7 |
Return on capital employed | % | 1.7 | 13.5 |
To see how CHEMFAB ALKALIS has performed over the last 5 years, please visit here.
Over the last one year, CHEMFAB ALKALIS share price has moved up from Rs 154.2 to Rs 445.6, registering a gain of Rs 291.4 or around 189.0%.
Overall, the S&P BSE SENSEX is up 0.8% over the year.
(To know more, check out historical annual results for CHEMFAB ALKALIS and quarterly results for CHEMFAB ALKALIS)
CHEMFAB ALKALIS currently trades at Rs 606.5 per share. You can check out the latest share price performance of CHEMFAB ALKALIS here...
The revenues of CHEMFAB ALKALIS stood at Rs 2,773 m in FY22, which was up 52.2% compared to Rs 1,822 m reported in FY21.
CHEMFAB ALKALIS' revenue has grown from Rs 1,787 m in FY18 to Rs 2,773 m in FY22.
Over the past 5 years, the revenue of CHEMFAB ALKALIS has grown at a CAGR of 11.6%.
The net profit of CHEMFAB ALKALIS stood at Rs 287 m in FY22, which was NA compared to Rs -81 m reported in FY21.
This compares to a net profit of Rs 254 m in FY20 and a net profit of Rs 168 m in FY19.
Over the past 5 years, CHEMFAB ALKALIS net profit has grown at a CAGR of 3.1%.
The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.
This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.
The cash flow statement of CHEMFAB ALKALIS reveals:
Here's the cash flow statement of CHEMFAB ALKALIS for the past 5 years.
(Rs m) | FY18 | FY19 | FY20 | FY21 | FY22 |
---|---|---|---|---|---|
From Operations | 446 | 410 | 542 | 454 | 549 |
From Investments | -301 | -466 | -581 | -64 | -210 |
From Financial Activity | -137 | 58 | 29 | -156 | -246 |
Net Cashflow | 7 | 2 | -10 | 234 | 93 |
Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.
The ratio/financial analysis of CHEMFAB ALKALIS reveals:
Here's the ratio/financial analysis of CHEMFAB ALKALIS for the past 5 years.
FY18 | FY19 | FY20 | FY21 | FY22 | |
---|---|---|---|---|---|
Operating Profit Margin (%) | 29.5 | 21.3 | 25.5 | 13.1 | 20.9 |
Net Profit Margin (%) | 14.6 | 8.7 | 12.4 | -4.5 | 10.6 |
Debt to Equity Ratio (x) | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 |
Equitymaster requests your view! Post a comment on "CHEMFAB ALKALIS 2021-22 Annual Report Analysis". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!